
    
      Primary objective: To demonstrate the superiority of topically administered 2PX versus
      placebo (vehicle) control in terms of reduction in pain intensity and physical function.

      Secondary objectives: To prospectively measure other efficacy variables of topically
      administered 2PX in pain associated with osteoarthritis of the knee. To evaluate the safety
      and tolerability of topically administered 2PX.
    
  